PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.95%
Revenue growth under 50% of ADI's 8.55%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.45%
Gross profit growth under 50% of ADI's 10.79%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.33%
Negative EBIT growth while ADI is at 15.07%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.33%
Negative operating income growth while ADI is at 15.07%. Joel Greenblatt would press for urgent turnaround measures.
0.90%
Net income growth under 50% of ADI's 8.88%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.79%
EPS growth under 50% of ADI's 9.46%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
1.82%
Diluted EPS growth under 50% of ADI's 8.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.94%
Share reduction while ADI is at 0.24%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.17%
Reduced diluted shares while ADI is at 0.25%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.03%
Dividend reduction while ADI stands at 0.05%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
22.29%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
10.25%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
163.00%
10Y revenue/share CAGR above 1.5x ADI's 57.26%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
25.66%
5Y revenue/share CAGR at 50-75% of ADI's 49.15%. Martin Whitman would worry about a lagging mid-term growth trajectory.
17.83%
3Y revenue/share CAGR similar to ADI's 17.91%. Walter Schloss would assume both companies experience comparable short-term cycles.
66.82%
Positive long-term OCF/share growth while ADI is negative. John Neff would see a structural advantage in sustained cash generation.
32.66%
5Y OCF/share CAGR above 1.5x ADI's 16.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
38.83%
3Y OCF/share CAGR above 1.5x ADI's 24.00%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
628.47%
Net income/share CAGR above 1.5x ADI's 182.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-62.18%
Negative 5Y net income/share CAGR while ADI is 101.39%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
30.50%
Below 50% of ADI's 75.93%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
33.35%
10Y equity/share CAGR at 50-75% of ADI's 61.72%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
14.54%
5Y equity/share CAGR at 50-75% of ADI's 19.41%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
24.70%
Below 50% of ADI's 50.53%. Michael Burry suspects a serious short-term disadvantage in building book value.
528.07%
Dividend/share CAGR of 528.07% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
328.75%
5Y dividend/share CAGR above 1.5x ADI's 81.37%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
29.76%
3Y dividend/share CAGR 1.25-1.5x ADI's 21.69%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
6.63%
AR growth well above ADI's 7.89%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.01%
Inventory growth well above ADI's 3.82%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
28.46%
Asset growth above 1.5x ADI's 12.26%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.09%
50-75% of ADI's 6.22%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.47%
R&D dropping or stable vs. ADI's 6.29%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
3.79%
SG&A growth well above ADI's 5.24%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.